7
Participants
Start Date
May 14, 2020
Primary Completion Date
April 18, 2021
Study Completion Date
April 18, 2021
Pemigatinib
13.5 mg once a day orally
Pembrolizumab
200 mg Q3W intravenously
Gemcitabine
1000 mg/m\^2 IV over 30 minutes on Days 1 and 8 of each 3-week cycle
Carboplatin
Dosed to target AUC of 5 mg/mL/min or 4.5 mg/mL/min if required per local guidelines on Day 1 or 2 of each 3-week cycle
Mount Sinai School of Medicine, New York
Ico Girona, Girona
Christiana Care Helen F. Graham Cancer Center, Newark
Irrcs Instituto Clinico Humanitas, Rozzano
Fondazione Irccs Ca Granda Ospedale Maggiore, Milan
Fondazione Irccs Istituto Nazionale Dei Tumori, Milan
Ieo Istituto Europeo Di Oncologia Irccs, Milan
Turku University Hospital, Sct Unit, Turku
Centre Hospitalier Universitaire de Besancon, Besançon
Hospital Clinico San Carlos, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario de La Paz, Madrid
Hospital Universitario Hm Sanchinarro, Madrid
Hospital Puerta de Hierro, Majadahonda
Charleston Hematology Oncology Associates, Charleston
Chu Nimes, Nîmes
Cotton-O'Neil Clinical Research Center, Hematology & Oncology, Marietta
Institut Claudius Regaud Oncopole Toulouse, Toulouse
Groupe Hospitalier Pellegrin Tripode, Bordeaux
Fonk Onkologian Klinikka, Tampere
Vanderbilt-Ingram Cancer Center, Nashville
L AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA POLICLINICO S. ORSOLA � MALPIGHI, Bologna
Hospital Universitario Virgen Del Rocio, Seville
Kliniken Maria Hilf, Mönchengladbach
Polyclinique de Blois, La Chaussée-Saint-Victor
Hospital Clinico Universitario de Valencia, Valencia
Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori, Meldola
Simmons Cancer Institute At Siu, Springfield
The University of Kansas Cancer Center, Westwood
Chu de Strasbourg Hopitaux Universitaires Service D Hematologie, Strasbourg
Iov - Istituto Oncologico Veneto Irccs, Bari
Istituto Tumori Giovanni Paolo Ii Irccs Ospedale Oncologico Bari, Bari
Groupe Hospitalier Pitie-Salpetriere, Paris
Hopital Cochin Cancerologie, Paris
Hopital Europeen Georges Pompidou (Hegp), Paris
The Center For Cancer and Blood Disorders, Fort Worth
Onc Consultants Pharmacy 2, Houston
Istituto Nazionale Tumori Fondazione Irccs G. Pascale, Napoli
Centre Hospitalier Universitaire de Poitiers, Poitiers
Marin Cancer Care, Greenbrae
Oregon Health & Science University, Portland
Spitalul Clinic Judetean de Urgenta 'Sf Apostol Andrei' Constanta, Constanța
Smhc Cancer Blood Disorders, Biddeford
Summit Medical Group, Florham Park
Wilhelminenspital, Vienna
Grand Hopital de Charleroi, Charleroi
Universitaire Ziekenhuis Leuven - Gasthuisberg, Leuven
Moncton Hospital - Horizon Health Network, Moncton
Helsinki University Meilahti Tower Hospital, Helsinki
University Hospital Waterford, Waterford
UNIVERSIT� CAMPUS BIO-MEDICO DI ROMA, Roma
Azosp S.Maria Sc Oncologia, Terni
Chiba University Hospital, Chiba
Chiba Cancer Center, Chiba
National Hospital Organization Kyushu Cancer Center, Fukuoka
Saitama Medical University International Medical Center, Hidaka-shi
Hirosaki University Hospital, Hirosaki-shi
Hakodate Goryokaku Hospital, Hokkaido
Sapporo Medical University Hospital, Hokkaido
Nihon University Itabashi Hospital, Itabashi-ku
Nara Medical University Hospital, Kashihara-shi
St. Marianna University School of Medicine Hospital, Kawasaki-shi
Kagawa University Hospital, Kita-gun
Nho Shikoku Cancer Center, Matsuyama
Toranomon Hospital, Minatoku
Osaka International Cancer Institute, Osaka
Saitama Medical Center Jichi Medical University, Saitama-shi
Tohoku University Hospital, Sendai
Jichi Medical University Hospital, Shimotsuke-shi
Keio University Hospital, Shinjuku-ku
Osaka University Hospital, Suita-shi
National Cancer Center Hospital, Tokyo
Toyama University Hospital, Toyama
Olsztynski Osrodek Onkologiczny Kopernik, Olsztyn
Champalimaud Foundation - Champalimaud Centre For the Unknown (Champalimaud Cancer Center), Lisbon
Fakultna Nemocnica S Poliklinikou Zilina, Žilina
Hospital Clinic I Provincial, Barcelona
Ico Institut Catala D Oncologia, Barcelona
Barts Health Nhs Trust - St Bartholomews Hospital, London
Lead Sponsor
Incyte Corporation
INDUSTRY